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domains with more comprehensive and commonly used neuropsychological measures to determine
the degree of overlap.
Methods: Data included individuals seen in an outpatient neurology clinic specializing in neurode-
generative disease whowere administered the MoCA and also underwent neuropsychological assess-
ment (n 5 471). A principal component analysis with varimax rotation was completed using the
MoCA domain scores and comprehensive neuropsychological evaluation measures.
Results: Four factors emerged accounting for 55.6% of the variance: (1) visuospatial/executive func-
tioning; (2) memory; (3) attention; and (4) language. The individual MoCA domain scores demon-
strated high factor loadings with standard neuropsychological measures purported to measure
similar cognitive constructs.
Discussion: These findings provide empirical validation for the MoCA domain classifications,
lending further support for the use of the MoCA as a cognitive screen that reflects similar constructs
as those measured by a comprehensive battery.
 2015 The Authors. Published by Elsevier Inc. on behalf of the Alzheimer’s Association. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
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The Montreal cognitive assessment (MoCA) [1] is a brief
cognitive screening measure commonly used for both clin-
ical and research purposes. It is often completed by primary
care doctors and neurologists to screen for cognitive decline,
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commons.org/licenses/by-nc-nd/4.0/).individuals with Alzheimer’s disease, which is expanding
exponentially, it is important to understand the relationship
between this brief screening measure and the current gold
standard of cognitive assessment: a full neuropsychological
evaluation. Current validated use of the MoCA is restricted
to interpretation of the total score, using a cutoff of less
than 26 to signify impairment, which has demonstrated
adequate sensitivity to cognitive impairment in a number
of clinical populations, including mild cognitive impairment
[1–4], Alzheimer’s disease [1,2], stroke [5,6], Parkinson’s
disease [7,8], and Huntington’s disease [9,10].
The extent to which performance on the MoCA relates to
general cognitive functioning as assessed by more detailed
neuropsychological tests has been explored, providing evi-
dence of convergent validity for the overall total score
[11,12]. Prior research has also compared the sensitivity
and specificity of the MoCA to detecting cognitiveimer’s Association. This is an open access article under the CC BY-NC-ND
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standard neuropsychological measures, and again found
adequate concurrent validity for the overall score
[1,3,5–7,13,14]. Comparatively few studies, however, have
examined the construct validity of the individual domain
scores. The primary aim of the present study was to
explore the construct validity of the individual MoCA
domain scores in an effort to determine the extent to which
those scores reflect similar cognitive constructs as those
measured by more traditional and comprehensive
neuropsychological measures.
Similar research conducted by Moafmashhadi and
Koski (2013) examined the factor structure of commonly
used neuropsychological measures and correlated the
calculated factor scores with the individual items of the
MoCA in a sample of geriatric clinical outpatients and
found significant, albeit modest, correlations between
their calculated factor scores and the MoCA items, sug-
gesting construct overlap. In their examination of the
sensitivity and specificity of the individual MoCA domain
scores at predicting impaired cognitive performance on
similar neuropsychological measures, the visuospatial/ex-
ecutive score demonstrated the best predictive accuracy;
however, the MoCA domain scores were generally poor
predictors of impairment on standard neuropsychological
measures and the authors caution against clinical interpre-
tation of domain scores [13]. Lam et al. (2013) found sig-
nificant correlations among MoCA domain scores and
respective neuropsychological domain scores in patients
with mild Alzheimer’s disease or mild cognitive impair-
ment. They found significant cross-correlations among
different domains with the highest correlation between
memory domains and the lowest between language do-
mains. For both the neuropsychological measures and
the MoCA items, they grouped subtests/items based on
the construct purportedly being measured, rather than us-
ing a statistical method of combining items based on
shared variance.
The following study addresses a gap in our current under-
standing: how the MoCA domain scores relate to more
comprehensive neuropsychological testing, without using
an a priori categorization of the neuropsychological mea-
sures. Here, we examine the construct validity of the
MoCA domain scores by using a factor analytic approach
to objectively explore the construct validity. Our goal was
to determine the extent to which the individual domain
scores load onto similar factors with comparable indices of
cognitive functioning taken from standard neuropsycholog-
ical measures.2. Methods
2.1. Participants
Data were drawn from a sample of individuals seen in a
subspecialty outpatient memory disorders clinic, special-izing in diagnosis and treatment of neurodegenerative dis-
ease (e.g., mild cognitive impairment, Alzheimer’s
disease, dementia with Lewy-bodies, frontotemporal de-
mentia, Parkinson’s disease). All patients were adminis-
tered the MoCA during their intake appointment with
neurology and were subsequently referred for neuropsy-
chological assessment as part of routine clinical care.
The analyzed sample consisted of 471 complete cases
and was 49.9% women and predominantly Caucasian
(91.3%) with an average age of 68.0 years (standard devi-
ation [SD] 5 9.3; range 25–92 years), average education
of 14.7 years (SD 5 2.8; range 7–20 years), and average
MoCA score of 22.3 (SD 5 4.0; range 5 8–30). Neuro-
psychological testing was completed within 180 days of
MoCA screening for all patients with an average interval
of 47.8 days (SD 5 45.8). This study was reviewed and
approved by the Institutional Review Board at the Cleve-
land Clinic (14-565), and all patients gave written
informed consent for the use of their data for research pur-
poses.2.2. Measures2.2.1. Montreal cognitive assessment
The MoCA is a manually administered paper-and-pencil
cognitive screening that takes approximately 10 minutes to
administer and with appropriate training can be adminis-
tered by multiple levels of health care providers (e.g., med-
ical assistants, nursing staff, physician assistants,
psychometrists, and so forth). It consists of 12 individual
tasks, most of which are binary, that are scored and summed
with a 6-item orientation screening and an educational
correction (i.e., one point added for individuals with 12 years
of education or less) to generate a total score representing
global cognitive functioning. The individual MoCA items
have been grouped into cognitive domains, including (1) vi-
suospatial and executive functioning, (2) naming, (3) atten-
tion (e.g., simple attention, working memory, vigilance), (4)
language (e.g., repetition, phonemic fluency), (5) abstrac-
tion, (6) delayed memory recall, and (7) orientation. Multi-
ple domain classifications have been suggested [1,2],
although none are currently validated for clinical
interpretation. The current analysis uses the original
domain organization established by the test authors.
2.2.2. Neuropsychological battery
All patients were evaluated using a comprehensive
neuropsychological battery as part of routine clinical care.
Measures included the brief visuospatial memory test,
revised (BVMT-R) [15] delayed recall score and copy score,
Hopkins verbal learning test, revised (HVLT-R) [16] delayed
recall score, Wechsler memory scale, fourth edition (WMS-
IV) [17] logical memory II, all five trails of the Delis-Kaplan
executive function system (DKEFS) [18] trail making test
(scanning, number sequencing, letter sequencing, switching,
Table 2
Neuropsychological and MoCA variable scores
Variable Mean SD
BVMT copy 11.01 1.24
Block design 29.23 9.69
DKEFS scanning 28.72 10.87
Numbers 53.07 25.48
Letters 57.33 28.90
Switching 140.50 61.67
Speed 38.21 21.40
Logical memory II 11.63 8.24
HVLT delayed 4.69 3.82
BVMT delayed 4.83 3.25
Digit span forward 9.43 2.20
Backward 7.44 2.17
Sequencing 6.67 2.52
Phonemic fluency (FAS) 31.51 11.51
Category fluency (animals) 15.30 5.08
Similarities 22.95 5.63
Boston naming test 50.94 8.62
MoCA visuospatial/executive 3.74 1.18
MoCA delayed memory 1.76 1.67
MoCA orientation 5.31 1.05
MoCA attention 5.03 1.18
MoCA naming 2.77 0.50
MoCA language 1.99 0.92
MoCA abstraction 1.39 0.78
Abbreviations: MoCA, Montreal cognitive assessment; SD, standard de-
viation; BVMT, brief visuospatial memory test; DKEFS, Delis-Kaplan ex-
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(FAS) and category (animal) fluencies, and the block
design, similarities and digit span subtests of the Wechsler
adult intelligence scale, fourth edition (WAIS-IV) [20].
Digit span scores were further subdivided into forward,
backward, and sequencing sections. Table 1 provides an
overview of the measures and descriptions of the scores
included in the analyses. Table 2 provides the mean and
SDs for each variable.
2.3. Data analysis
A principal component analysis (PCA) with varimax
rotation was completed using the 6 MoCA domain scores,
the orientation score, and analogous cognitive measures
completed on the same individuals as part of a comprehen-
sive neuropsychological evaluation. An overall test battery
mean (OTBM) [21] was also calculated for the neuropsy-
chological battery by converting all age-adjusted standard-
ized scores to a common metric (i.e., T scores) and
calculating the resulting mean in an effort to create a value
analogous to the MoCA total score. The average OTBM for
the sample was 45.7 (SD 5 6.9; range 5 24.5–62.5).
Although not included in the PCA, the relationship be-
tween the MoCA total and OTBM was evaluated using
the Pearson product-moment correlation coefficient.Table 1
Neuropsychological and MoCA variables used in factor analysis
Measure Scores used
BVMT copy Copy of simple figures
WAIS-IV block design Raw score
DKEFS trail making test Time to complete each of the five trails
WMS-IV logical
memory II
Sum of delayed recall of two stories
HVLT-R Sum of delayed recall of a word list
BVMT-R Sum of a delayed recall of simple figures
WAIS-IV digit span Raw score of forward, backward, and
sequencing
Phonemic fluency Sum of words produced beginning with
letters F, A, and S
Category fluency Sum of words produced in the semantic
category animals
WAIS-IV similarities Raw score
Boston naming test Number of pictures correctly named
MoCA visuospatial/
executive
Sum of trails switching, cube copy, and clock
drawing
MoCA delayed memory Sum of uncued delayed recall of five words
MoCA orientation Sum of orientation for date and location
MoCA attention Sum of digit span forward, backward,
vigilance, and serial 7
MoCA naming Sum of naming three pictures
MoCA language Sum of repetition ability and phonemic
fluency (F)
MoCA abstraction Sum of similarities between words
Abbreviations: MoCA, Montreal cognitive assessment; BVMT, brief
visuospatial memory test; WAIS-IV, Wechsler adult intelligence scale,
fourth edition; DKEFS, Delis-Kaplan executive function system; WMS-
IV, Wechsler memory scale, fourth edition; HVLT, Hopkins verbal learning
test.
ecutive function system; HVLT, Hopkins verbal learning test.3. Results
The OTBM significantly correlated with the MoCA total
score, r 5 0.66, P , .001, indicating a significant relation-
ship among overall MoCA performance and overall perfor-
mance on a larger, more comprehensive neuropsychological
battery.
Four factors emerged in the PCA. All four components
had eigenvalues .1 and in total they accounted for 55.6%
of the variance (Table 3). The number of components was
chosen based on eigenvalues ,1, the scree test, and mini-
mal partial average test, which all converged on extraction
of four components. Loading on the first component was
the MoCA visuospatial/executive score, the BVMT copy
score, block design, and all five trails of the trail making
test. This component was labeled the visuospatial/executive
factor and accounted for the greatest amount of variance,
with component loadings ranging from 0.45 (BVMT
copy) to 20.79 (DKEFS number sequencing). Given that
the scores on the DKEFS trail making test reflect time to
completion, such that lower times reflect better perfor-
mance, the negative component loadings reflect the
expected relationship.
The second component, memory, consisted of the
MoCA delayed recall and orientation scores, as well as
the delayed recall scores from logical memory, HVLT,
and BVMT and represented the clearest component loading
patterns. The orientation score generated the lowest loading
Table 3
Factor loadings
Variable
Factor
1 2 3 4
MoCA visuospatial/executive 0.533
BVMT copy 0.451
Block design 0.698
DKEFS scanning 20.678
Numbers 20.792
Letters 20.732
Switching 20.650 20.383
Speed 20.740
MoCA delayed 0.781
MoCA orientation 0.576
Logical memory II 0.821
HVLT delayed 0.790
BVMT delayed 0.768
MoCA attention 0.583
MoCA language 0.587 0.364
Digit span forward 0.738
Backward 0.747
Sequencing 0.362 0.511
Phonemic fluency (FAS) 0.604
MoCA naming 0.727
MoCA abstraction 0.434
Similarities 0.352 0.632
Category fluency (animals) 0.550
Boston naming test 0.785
Eigenvalue 7.77 2.36 1.82 1.39
Proportion of variance (rotated), % 17.56 14.19 12.75 11.15
Abbreviations: MoCA, Montreal cognitive assessment; BVMT, brief vi-
suospatial memory test; DKEFS, Delis-Kaplan executive function system;
HVLT, Hopkins verbal learning test.
NOTE. Loadings ,0.350 were suppressed from the Table.
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discrepant from the other measures within this component.
The remaining variables loading on the memory compo-
nent exceeded 0.75, with the highest noted for the HVLT
delayed recall score, which most closely parallels the mem-
ory component of the MoCA (i.e., word list recall).
The third component, labeled attention, was the most
variable and consisted of the MoCA attention and lan-
guage scores, as well as the digit span scores (i.e., for-
ward, backward, and sequencing), and phonemic
fluency. The switching trial of DKEFS trails and similar-
ities subtest of the WAIS-IV also loaded on this compo-
nent, although to a lesser degree, and both of these
variables showed stronger loadings with other factors.
Although not all tasks within this component were clearly
related to attention, the highest loadings were noted for
the attentional measures. The loadings of the DKEFS
switching and phonemic fluency may reflect the atten-
tional components of these measures but the relationship
between similarities and the remaining measures is less
clear. Had the similarities subtest showed the highest
loading on this component, labeling it as measuring atten-
tion would have been more difficult; however, this was not
the case and the loading was modest by comparison.The final component, language, consisted of the MoCA
naming, language, and abstraction scores, as well as DKEFS
category fluency, BNT, and similarities. Given that the pre-
ponderance of these indices relate to language functions,
the chosen label was felt most appropriate. Interestingly,
the MoCA language domain did not show the highest
loading with this factor, which is discussed in the following.4. Discussion
The individual MoCA domain scores demonstrated high
factor loadings with standard neuropsychological measures
purported to measure similar cognitive constructs, providing
empirical validation for the construct validity of the MoCA
domain classifications. These findings lend further support
for the use of the MoCA as a brief screen of cognition that
reflects similar constructs as those gleaned from a more
comprehensive battery. Most notably, the memory domain
from theMoCA demonstrated a strong association with stan-
dard neuropsychological measures of memory and of the in-
dividual MoCA domain scores demonstrated the strongest
loading. This is of particular relevance to practitioners work-
ing with neurodegenerative disease populations, as individ-
uals demonstrating poor memory performance on the
MoCA are likely to also demonstrate memory impairment
on more comprehensive neuropsychological testing, vali-
dating the utility of the MoCA as a memory screening
tool. What remains unclear is whether similar impairment
profiles emerge on theMoCA as those onmore standard neu-
ropsychological measures (e.g., retrieval vs. encoding defi-
cits), which could further aid in refining differential
diagnoses; this reflects an empirical question of interest
and target of future study.
A significant advantage of theMoCA over other cognitive
screening measures is the breadth of cognitive domain
coverage beyond memory, which increases its clinical util-
ity, particularly for detection of individuals presenting with
nonamnestic cognitive changes. As shown by the present
findings, performance on the MoCA is also sensitive to
visuospatial ability and executive functioning, attention, as
well as language and that the standard domain organization
developed by the authors of theMoCA parallels that which is
measured by more comprehensive assessment. One limita-
tion of the present study is the long wait times between the
administration of the MoCA and the full neuropsychological
battery (e.g., up to 180 days). The time between MoCA and
full neuropsychology testing is an organic factor of wait
times for a neuropsychological evaluation at the time of
data collection. Although there may be some progression
of symptoms in the interim, wewould expect the progression
to manifest similarly within domains, so would likely not
have an impact on our results.
Although most measures were clearly associated with a
single construct, several measures demonstrated multiple
associations. The most evenly distributed was the digit
span sequencing score, a measure of verbal workingmemory
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(0.36) and the attention component (0.51), which is consis-
tent with previous literature suggesting that working
memory, particularly mental manipulation, requires both
attention, as well as executive demands [22,23]. The
MoCA language score was strongly associated with the
attention component, as well as the language component,
albeit to a lesser degree. Reviewing the items comprising
the MoCA language score finds that 2 of 3 possible points
are derived from a repetition task, which requires basic
attention to complete and may account for the higher
loading on attention. Similarly, the WAIS-IV similarities
subtest, which requires verbal abstract reasoning and
concept formation, showed a split-loading, associating
strongly with the language component but also with the
attention component. The switching trial of DKEFS trails
was also associated with two components, including the
visuospatial/executive component and the attention compo-
nent, which may be attributable to the executive demands
required to switch effectively, as well as the working
memory demands required to maintain set.
Although the present study supports the construct validity
of the MoCA when compared with more comprehensive
neuropsychological measures, it does not evaluate the diag-
nostic sensitivity and specificity of the domain scores. In
previous research, when the diagnostic sensitivity and spec-
ificity of the MoCAwas compared with a full neuropsycho-
logical evaluation, the total MoCA score has been found to
have high sensitivity but low specificity [5,7], which is to
be expected given the broad sampling of cognitive
constructs. Although poor specificity precludes use of the
MoCA as a diagnostic tool, the high sensitivity reinforces
the notion that the MoCA is a valuable screening tool that
can be used to guide clinical decision making to help
determine when more comprehensive neuropsychological
testing would be beneficial.
As suggested in previous research, a score below the cut-
point warrants a full neuropsychological evaluation to better
characterize the extent of cognitive impairment and more
thoroughly evaluate an individual’s cognitive pattern of per-
formance. Because of the high correspondence between
MoCA domain scores and standard neuropsychological
measures, our results also suggest the MoCA can provide a
qualitative understanding of an individual’s performance
on subdomains, even though the deficit may be highly spe-
cific. Furthermore, although our findings are suggestive of
the utility of the MoCA to assess the overall cognitive profile
of patients and future research may find that the cognitive
profiles produced with the MoCA are diagnostically useful,
clinical use of scores other than the total score has not been
validated. Until such time, the MoCA remains an excellent
tool for cognitive screenings, which have their place in
many contexts. Comprehensive neuropsychological assess-
ment, however, when and where available remains the
preferred method for generating a more refined profile
regarding cognitive functioning.Acknowledgments
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1. Systematic review: The authors used traditional sour-
ces (e.g., PubMed) to review the literature. It was
found that the Montreal cognitive assessment
(MoCA) has been evaluated in comparison with stan-
dard neuropsychological batteries using a priori
cognitive domain classifications. These studies are
discussed and appropriately cited.
2. Interpretation: Our findings lend further support for
the use of the MoCA as a brief screen of cognition,
with the additional finding that the MoCA domains
appear to reflect similar constructs as those gleaned
from a more comprehensive neuropsychological bat-
tery.
3. Future directions: Although the present study sup-
ports the construct validity of the MoCA domain
scores when compared with more comprehensive
neuropsychological measures, it does not evaluate
the diagnostic sensitivity and specificity of the
MoCA domain scores, which would be a valuable
future direction. Future research may also consider
using more heterogeneous samples with regard to
clinical diagnosis.References
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